In-Cell Biochemistry Using NMR Spectroscopy by Burz, David S. & Shekhtman, Alexander
In-Cell Biochemistry Using NMR Spectroscopy
David S. Burz, Alexander Shekhtman*
Department of Chemistry, State University of New York at Albany, Albany, New York, United States of America
Abstract
Biochemistry and structural biology are undergoing a dramatic revolution. Until now, mostly in vitro techniques have been
used to study subtle and complex biological processes under conditions usually remote from those existing in the cell. We
developed a novel in-cell methodology to post-translationally modify interactor proteins and identify the amino acids that
comprise the interaction surface of a target protein when bound to the post-translationally modified interactors. Modifying
the interactor proteins causes structural changes that manifest themselves on the interacting surface of the target protein
and these changes are monitored using in-cell NMR. We show how Ubiquitin interacts with phosphorylated and non-
phosphorylated components of the receptor tyrosine kinase (RTK) endocytic sorting machinery: STAM2 (Signal-transducing
adaptor molecule), Hrs (Hepatocyte growth factor regulated substrate) and the STAM2-Hrs heterodimer. Ubiquitin binding
mediates the processivity of a large network of interactions required for proper functioning of the RTK sorting machinery.
The results are consistent with a weakening of the network of interactions when the interactor proteins are phosphorylated.
The methodology can be applied to any stable target molecule and may be extended to include other post-translational
modifications such as ubiquitination or sumoylation, thus providing a long-awaited leap to high resolution in cell
biochemistry.
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Introduction
The ultimate goal of all structural and biochemical research is to
understand how macromolecular interactions give rise to and
regulate biological activity within a natural environment, i.e. in
living cells. The challenge is formidable due to the complexity of
living matter and the relative scarcity of appropriate in vivo
methods. The specific interactions between proteins that partic-
ipate in signal transduction processes are further complicated by
post-translational modifications (PTM) of protein structure. PTM
is a mechanism for regulating cellular processes; such modifica-
tions can alter the strength or number of interactions in which
these proteins engage and/or redirect them to sub-cellular
compartments as required for proper functioning [1]. For
example, endocytosis of receptor tyrosine kinases (RTKs) requires
tyrosine phosphorylation and monoubiquitination of the receptor
and downstream components to sort endocytosed cargo for
subsequent degradation (down regulation) or recycling to the cell
surface [2,3,4].
To examine the effect of PTM on protein-protein interactions
that occur along this signaling pathway, we developed an in-cell
biochemical methodology that, in combination with recently
developed STINT-NMR (Structural Interactions using NMR
spectroscopy) [5], allows us to directly observe the structural
changes in the interaction surface of a target protein that result
from phosphorylating interactor proteins. Since protein phosphor-
ylation does not occur in E. coli, we can use these cells as a test tube
for performing in-cell biochemistry, introducing the target protein,
interactor proteins and kinase activity on separately inducible
plasmids (Fig. 1ab). By employing a target protein that does not
interact with endogenous bacterial proteins, the structural details
of the specific interaction between these molecules can be observed
in the absence and presence of post-translational modification
within a cellular environment.
STINT-NMR is an in-cell technique[6,7] for examining the
structural changes in a target protein resulting from protein-
protein interactions [5,8]. Protein overexpression is first induced in
uniformly labeled medium [U,
15N-] to produce a target protein
containing NMR-active nuclei. The cells are washed and
resuspended in non-labeling medium to induce overexpression of
the interactor protein(s). We then use
15N-edited heteronuclear
single quantum coherence (
1H{
15N}-HSQC) NMR experiments
to monitor changes in the chemical shifts of target backbone amide
nuclei as the concentration of the interactor(s) increases. In cases
where the target binds to a high molecular weight interactor
protein, we monitor changes in the NMR spectrum of the free
target since only this species gives rise to visible peaks. Depending
on the chemical exchange rate between the free and bound states
of the target, affected NMR peaks, corresponding to backbone
amides, can either shift, broaden their line shape or disappear
completely, thereby delineating the intermolecular interaction
surface between the target and the interactor(s). By changing the
isotopic composition on induction, we selectively label the target
while the interactor proteins remain cryptic, thus reducing NMR
spectral complexity. The resulting NMR data provide a complete
titration of the interaction and identify the amino acids that
comprise the interaction surface of a target protein. It is important
to note that in-cell titrations lack the precision of binding isotherms
that are obtained in vitro because of the variable levels of protein
expression that are inherent when using living cell, and thus, are
largely qualitative. However, in each case, the same structural
endpoint is attained. Tight temporal control over protein
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phosphorylation, by expressing a kinase domain capable of post-
translationally modifying the interactor protein, off an inducible
plasmid (Fig. 1ab).
To demonstrate the efficacy of this methodology, we examined
changes in the binding surface of a Ubiquitin (Ubq) target that result
from phosphorylating the endocytic proteins, STAM2 (Signal-
transducing adaptor molecule) and Hrs (Hepatocyte growth factor-
regulated tyrosine kinase substrate), both of which form homodimers
with molecular weights of ,115 kDa and ,150 kDa, respectively.
The STAM2-Hrs heterodimer (MW ,132 kDa) directs trafficking
of endocytosed, monoubiquitinated RTKs to the cell surface for
recycling or to lysosomes for degradation. Several lines of evidence,
mostly from the study of yeast membrane proteins, suggest that
receptor sorting through endocytosis and subsequent degradation is
controlled by ubiquitination of both the internalizing receptors and
components of the endocytic machinery [9].
In addition to monoubiquitination, endocytic proteins undergo
tyrosine phosphorylation, in some cases mediated by Src-family
kinases [10], in response to cytokines or growth factor binding to
RTKs. Indeed, phosphorylation of tyrosine residues on STAM2
and Hrs occurs during endocytosis. These two post-translational
modifications seem to be linked since, in at least some cases,
tyrosine phosphorylation is monoubiquitination-dependent [11].
The precise biological role of phosphorylation is unclear but, at
least for Hrs, it was shown to be important in the cellular
localization of the protein [10]. The molecular machinery that
sorts endocytosed membrane proteins into the degradative
pathway and away from the default recycling pathway is an area
of intense research. This is because down regulation of receptor
signaling provides a means to attenuate proliferation and minimize
cell growth. The loss of control of down regulation can lead to
rampant growth characteristic of most cancers.
STAM2 and Hrs have a modular domain architecture that
allows them to participate in multiple protein-protein interactions
and to bind the surrounding lipid bilayer[12] (Fig. 1c). Free
Ubiquitin and monoubiquitinated proteins bind to the Ubiquitin
interacting motif (UIM) present on STAM2 and Hrs [13], and to
the N-terminal VHS domain of STAM2 [14]. STAM2 and Hrs
are also monoubiquitinated, possibly at multiple sites, in a signal-
dependent manner that requires the function of the UIM. Thus,
UIM-containing monoubiquitinated protein may further assemble
other monoubiquitinated and UIM-containing proteins in recep-
tor-bound macromolecular complexes that contribute to the
events leading to intracellular signal transduction and to receptor
sorting in endocytic vesicles.
The main objectives of the experiments presented here are to
demonstrate that we can regulate the post-translational modifica-
tion of overexpressed proteins in bacterial cells, a process we dub
in-cell biochemistry, and to identify structural changes in protein
interaction surfaces due to presence of PTMs using in-cell NMR
spectroscopy. These objectives were accomplished by successfully
tyrosine phosphorylating STAM2 and Hrs (Fig. 1d), both of which
undergo this post-translational modification to function in the
Figure 1. Sequential overexpression and in-cell post-transla-
tional modification of interacting proteins for STINT-NMR. E.
coli are transformed with up to three compatible plasmids and grown
overnight in LB-glucose medium containing antibiotics. The cells are
washed and resuspended in label-free medium. a) IPTG is used to
induce overexpression of interactor proteins, STAM2 and Hrs, which
form heterodimers. L-arabinose is then used to induce overexpression
of Fyn kinase, which phosphorylates tyrosine residues (PY) on the
interactors. b) The cells are washed and resuspended in labeling
medium. Anhydrotetracycline is used to induce overexpression of
uniformly labeled [U-
15N] Ubiquitin target protein, which binds to the
interactors. Samples are taken as the concentration of target increases.
Changes in the target protein structure are monitored using in-cell NMR
spectroscopy. A sample of labeled target containing no interactor is
prepared separately as a reference. N.b. The experiment can be
performed using a single interactor protein and without post-
translational modification. The protocol can also be reversed, overex-
pressing labeled target first, followed by interactor(s) and post-
translational modification (see Materials and Methods). c) Domain
structure of STAM2 and Hrs. VHS (Vps27-Hrs-Stam domain); UIM
(ubiquitin interacting motif); SH3 (src homology domain 3); CC (coiled
coil domain); FYVE (FYVE-finger domain); up arrows indicate Ubiquitin,
STAM2 or Hrs binding domain. d) Western blot of overexpressed
interactor proteins from whole cells in the absence and presence of
overexpressed Fyn kinase, probed with anti-tyrosine phosphate HRP-
conjugate antibody. Lane 1: STAM2; lane 2: STAM2 & Fyn kinase; lane 3:
Hrs; lane 4: Hrs & Fyn kinase; lane 5: STAM2 & Hrs; lane 6: STAM2, Hrs &
Fyn kinase; Lane 7: MW.
doi:10.1371/journal.pone.0002571.g001
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surfaces of Ubiquitin when bound to these post-translationally
modified proteins by using STINT-NMR.
Results
In-cell spectrum of Ubiquitin is distinct from that
obtained in vitro
There are noticeable differences between the solution and in-
cell NMR spectra of free Ubiquitin, with only 86% of the
Ubiquitin peaks observed in solution found within 0.1 ppm of
those observed in cells [15]. To rule out the possibility that the
NMR spectrum of Ubiquitin is due to extracellular protein
[16,17], after obtaining the in-cell NMR spectrum, the cells were
centrifuged and the supernatant was examined. No NMR
spectrum of Ubiquitin was observed above noise level (Fig. S1),
implying that there is no leakage or cell lysis occurring during the
time it takes to acquire the NMR spectrum.
Binding non-phosphorylated interactor proteins creates
unique contact surfaces on Ubiquitin
To dissect changes in the interaction surface of Ubiquitin we
created complexes of [U-,
15N]-Ubiquitin-STAM2, [U-,
15N]-
Ubiquitin-Hrs, and [U-,
15N]-Ubiquitin-STAM2-Hrs (Fig. 2, Fig.
S2). To study Ubiquitin binding to STAM2, we induced
overexpression of [U-,
15N]-Ubiquitin prior to or following 3 or
4 hours of STAM2 overexpression. Over this time, the concen-
tration of STAM2 was determined to range from 50–500 mMi n
these cells. As the concentration of STAM2 increased, we
observed consistent broadening of selected Ubiquitin peaks in
the NMR spectrum[5] (Fig. S2). The NMR solution structure of
Ubiquitin, which consists of 76 amino acids, is well-known [15].
Mapping the differentially broadened peaks onto the three-
dimensional structure of Ubiquitin results in two distinct surfaces
that define the interface between Ubiquitin and STAM2[5]
(Fig. 3a). The chemical shift changes of Ubiquitin that we observed
affect only surface residues, implying that there are no conforma-
tional changes accompanying complex formation. The first
interface corresponds to the UIM binding surface and consists of
residues K6, L8, I44, A46, G47, H68 and V70; the second
interface corresponds to the binding surface for the VHS domain
of STAM2 and consists of K11, I13, K27, K29, K33 and K63.
High affinity binding by STAM2 to Ubiquitin requires both the
UIM and the VHS [14]. Since the overall binding affinity of
Ubiquitin for STAM2 is ,10 mM versus ,100 mM for the UIM
alone [5], we conclude that the second interacting surface is
responsible for increasing the overall affinity of the interaction.
To study Ubiquitin binding to Hrs, we induced overexpression
of [U-,
15N]-Ubiquitin prior to or following 3 or 4 hours of Hrs
overexpression. Over this time, the concentration of Hrs was
determined to range from 50–360 mM in these cells. As the
concentration of Hrs increased, we observed changes in the
chemical shifts of selected Ubiquitin peaks (Fig. 2a). Mapping the
chemically-shifted peaks onto the three-dimensional structure of
Ubiquitin results in a distinct interface between Hrs and Ubiquitin
(Fig. 3b) corresponding to the UIM binding surface and consisting
of residues K6, L8, I44, A46, G47, H68 and V70. In addition,
R72, located near the C-terminus, was affected, resulting in an
extension of the UIM binding patch. The reported binding affinity
of Ubiquitin for Hrs is ,200 mM; this is slightly weaker than the
binding of an isolated UIM to Ubiquitin [18]. The UIM of Hrs is a
variant of the conventional UIM helix, dubbed a double UIM
(DUIM), and is capable of binding two Ubiquitin molecules [19].
The small changes in the NMR spectra observed for the
interaction between the UIM of STAM2 and the DUIM of Hrs
may result from an altered structure for the DUIM.
To study Ubiquitin binding to the STAM2-Hrs heterodimer,
we induced overexpression of [U-,
15N]-Ubiquitin prior to or
following 3 or 4 hours of STAM2 and Hrs co-overexpression. The
concentrations of STAM2 and Hrs were determined to range from
50 to 280 mM and from 20 to 100 mM, respectively, in these cells.
As the concentrations of STAM2 and Hrs increased, we observed
consistent broadening of selected Ubiquitin peaks (Fig. 2b).
Mapping the differentially broadened peaks onto the three-
dimensional structure of Ubiquitin results in two distinct interfaces
between Ubiquitin and STAM2-Hrs (Fig. 3c). The first interface
corresponds to the UIM binding surface and includes residues K6,
L8, I44, A46, G47, H68 and V70. The second interface includes
residues K27, K29, K33, Q62 and K63, which are part of the
Ubq-VHS contact surface, but not K11 and I13, which are
perturbed in the interaction between Ubiquitin and STAM2. The
change in the Ubq-VHS interaction surface is subtle, truncated at
one end and slightly extended at the other, in a manner that is
characteristic of the ternary complex and may be a result of
STAM2 reorienting within the heterodimer relative to STAM2
alone since these residues are not affected when Hrs binds to
Ubiquitin. Overall, the surface residues on Ubiquitin that interact
with the UIM are virtually the same as those observed for the
Ubq-STAM2 and Ubq-Hrs interactions, indicating that the
binding of the UIM to Ubiquitin is largely unaltered.
Binding phosphorylated interactor proteins results in the
loss of contact surfaces on Ubiquitin
STAM2 and Hrs were phosphorylated by inducing overexpres-
sion of the constitutively active Src-family tyrosine-kinase, Fyn, for
the final 2 hours of STAM2, Hrs, or STAM2-Hrs overexpression.
The extent of STAM2 and Hrs phosphorylation were examined
by using Western blots (Fig. 1d). Mass spectroscopic analysis (see
Methods S1) of STAM2 revealed that Y291, Y371 and Y374 are
phosphorylated by Fyn (Fig. S3). A major site of phosphorylation
on STAM2 is reported to be Y192 [20], however, the absence of
detectable phosphorylation at Y192 likely reflects the inability of
Fyn to phosphorylate at that position. This is not unexpected since
distinct non-receptor tyrosine kinases couple EGF, HGF and
PDGF stimulation with tyrosine phosphorylation of STAM2 and
Hrs in vivo [10]. Y371 and Y374 are located in the ITAM
(immunoreceptor tyrosine-based activation motif) domain, which
contains sites for phosphorylation by Src kinase. The ITAM
domain has been identified as necessary for tyrosine phosphory-
lation of STAM2 by Jak1 [21].
We did not confirm phosphorylation sites in Hrs since these sites
have been well-established. The major sites of EGF-dependent
phosphorylation on human Hrs are Y329 and Y334 [22].
Tyrosine to phenylalanine mutations at these residues do not
affect Ubq-Hrs binding, Hrs ubiquitination, or the activity of Hrs
in the sorting mechanism [22]. Furthermore, an intact UIM is
required for Hrs phosphorylation [22]. Extensive tyrosine
phosphorylation of Hrs was not confirmed (Fig. 1d) suggesting
that Fyn kinase is likely not the optimal kinase to phosphorylate
Hrs. The extent of tyrosine phosphorylation on Hrs appeared to
be enhanced by the presence of Ubiquitin (not shown). Indeed, it
was previously noted that Hrs phosphorylation may require direct
interaction between Ubiquitinated receptors and Hrs [10].
The STINT-NMR spectrum of Ubiquitin interacting with
phosphorylated STAM2 reveals primarily changes in chemical
shifts that affect a smaller number of residues than were perturbed
in the Ubq-STAM2 interaction, and the loss of the interaction
surface attributed to the VHS domain of STAM2 (Fig. S2c;
In-Cell Biochemistry
PLoS ONE | www.plosone.org 3 July 2008 | Volume 3 | Issue 7 | e2571Fig. 3d). That the NMR spectrum represents an interaction
between Ubiquitin and phosphorylated STAM2 is implicit since a
population of .70–80% modified interactor is required to
generate a unique set of chemical shifts. We estimate that the
affinity of Ubiquitin for phosphorylated STAM2 is .100 mM
(refer to Materials and Methods), which is comparable to that of
the isolated UIM. One additional residue, R74, was perturbed as a
result of phosphorylated STAM2 binding to Ubiquitin suggesting
a slight rearrangement of the UIM and possibly a change in the
overall binding affinity.
To verify that the Ubiquitin residues perturbed when STAM2 is
phosphorylated are due to the post-translational modification, we
mutated the ITAM tyrosine residues, 371 and 374, to phenylal-
anines (Y371/4F-STAM2). When this mutant is overexpressed
and its interaction with Ubiquitin examined by using STINT-
NMR, the resulting spectra (Fig. S2) and surface interaction maps
Figure 2. NMR-spectra of Ubiquitin-ligand complexes.
1H{
15N}HSQC spectra of E. coli after 3-h of [
15N]-Ubiquitin overexpression (black),
overlaid with spectra (red) obtained from E. coli after 2-h of [
15N]-Ubiquitin overexpression and: a) 4-h of Hrs overexpression; b) 4-h of STAM2 & Hrs
co-overexpression; c) 4-h of Hrs and 2-h of Fyn kinase co-overexpression; d) 4-h of Hrs & STAM2 and 2-h of Fyn kinase co-overexpression. Individual
peaks exhibiting either a chemical shift change .0.1 ppm or significant differential broadening (.30% change in intensity) are labeled with
corresponding assignments. The strong peaks in the spectra between 8.5 and 7.8 ppm correspond to various metabolites of [U-
15N] ammonium ion.
NMR experiments were acquired at T=298 K on Bruker Avance 700 MHz NMR spectrometer equipped with a cryoprobe.
1H{
15N}-edited HSQC data
were recorded with 16 transients as 512{128} complex points, apodized with a squared cosine-bell window function and zero-filled to 1k{256) points
prior to Fourier transformation. The corresponding sweep widths were 12 and 35 ppm in the
1H and
15N dimensions, respectively. The Q49 peak is
obscured by peaks from the [U-
15N] ammonium ion metabolites and is not labeled. Ubiquitin ligands are indicated in each panel.
doi:10.1371/journal.pone.0002571.g002
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are largely identical to those obtained using unphosphorylated
wild-type STAM2. Small differences between the spectra are likely
due to the fact that at least one additional Fyn-dependent tyrosine
phosphorylation site (Y291) was still present in the mutant. We
conclude that phosphorylating the ITAM tyrosines weakens the
binding between Ubiquitin and STAM2, and infer that these
residues may be critical for the processivity of the internalizing
pathway, attenuating the binding affinity of Ubiquitin for STAM2
in response to post-translational modification.
In spite of the fact that we did not confirm extensive
phosphorylation of Hrs by Fyn kinase (Fig. 1d), the NMR spectrum
of Ubiquitin interacting with Hrs changes when Fyn kinase is
expressed in the same cells providing indirect evidence for Hrs
phosphorylation. The STINT-NMR spectrum of Ubiquitin inter-
acting with phosphorylated Hrs (Fig.2c) shows primarily changes in
chemical shifts that affect a larger number of residues than were
perturbed in the Ubq-Hrs interaction (Fig. 2a). When these changes
are mapped to the Ubiquitin surface, K6, L8, I44, A46, G47, Q49,
H68, V70 and R74, are seen to participate in the interaction,
whereasR72isnolongerpartoftheinteractionsurface(Fig.3e).The
change in the chemical shift of R74, a residue that was also
implicated in the interaction between Ubiquitin and phosphorylated
STAM2, suggests that a similar alteration of the Ubq-UIM
interaction occurs when Ubiquitin binds to either phosphorylated
molecule. We estimate that the overall binding affinity of Ubiquitin
for phosphorylated Hrs is .100 mM, which is comparable to the
affinity of Ubiquitin for unphosphorylated Hrs and the isolated
UIM. Thus, phosphorylating tyrosines on Hrs does not appreciably
alter the binding of Ubiquitin to Hrs.
The STINT-NMR spectrum of Ubiquitin interacting with
phosphorylated STAM2-Hrs reveals changes in chemical shifts for
a number of residues (Fig. 2d) and the loss of the interacting
surface attributed to the VHS domain of STAM2 (Fig. 3f). The
residues associated with UIM binding to Ubiquitin (K6, L8, I44,
A46, G47, H68 and V70) are perturbed. However, residue R74,
which is chemically shifted in the interaction between Ubiquitin
and phosphorylated STAM2 or phosphorylated Hrs alone, is not
perturbed. Ubiquitin appears to interact with the phosphorylated
ternary complex in much the same way that it interacts with
phosphorylated STAM2 and phosphorylated Hrs, involving
contact with only the UIMs of both interactor proteins and a
commensurate weakening of the binding due to the loss of the
second interaction surface.
Discussion
There are advantages to using in-cell rather than in vitro NMR
experiments to study interacting proteins: 1) the proteolytic
machinery in cells is tightly regulated and this regulation is lost
Figure 3. Interaction surface maps of Ubiquitin-ligand complexes. Interaction surface of Ubiquitin mapped onto the three-dimensional
structure of Ubiquitin (PDB code 1D3Z). Individual residues exhibiting either a chemical shift change .0.05 ppm or significant differential broadening
are indicated in red. All perturbed residues lie on the Ubiquitin surface and, therefore, reflect changes in the interaction surface of the molecule rather
than changes in tertiary or quaternary structure. a) STAM2-Ubq interaction; b) Hrs-Ubq interaction; c) STAM2-Hrs-Ubq interaction; d) phosphorylated
STAM2-Ubq interaction (YP-STAM2); e) phosphorylated Hrs-Ubq interaction (YP-Hrs); f) phosphorylated STAM2-Hrs-Ubq interaction (YP-STAM2-Hrs).
Ubiquitin ligands are indicated in each panel.
doi:10.1371/journal.pone.0002571.g003
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protein overexpression results in higher local concentrations of
interacting partners than in lysates, thus increasing the likelihood
of detecting weak interactions; 3) interactions occur within a
cellular environment, which may confer biologically relevant
structural conformations that cannot be duplicated in vitro.
Hrs and, to a lesser extent, STAM2, are somewhat labile.
Therefore working with purified protein and performing in vitro
binding assays are not feasible for either of these species.
Furthermore, in vitro binding assays will not provide any structural
details about the interaction, but will merely provide a more
precise estimate of binding affinities. While the affinities that we
estimated are consistent with those reported from in vitro
studies(Shekhtman, 2002), we are primarily concerned with the
interaction surfaces on Ubiquitin and how modulating these
surfaces affects the processivity of the internalizing pathway.
Applying in-cell biochemistry using NMR spectroscopy to the
ternary Ubiquitin-Hrs-STAM2 complex showed that the interac-
tion surface is significantly modulated by the phosphorylation state
of two STAM2 tyrosines, Y371 and Y374, located in the
conserved ITAM domain. Since the ITAM domain is in
immediate proximity to the STAM2 homo- and hetero-dimeriza-
tion domain GAT [23], we expect that a change in the
phosphorylation state of Y371 and Y374 will cause intermolecular
rearrangements of the Ubiquitin-binding domains, VHS and
UIM, leading to the observed loss of the VHS binding surface.
Our data cannot distinguish whether Ubiquitin binds separately
to the VHS and to the UIM (two Ubiquitins bound per STAM2)
or if the two binding motifs interact cooperatively to increase the
overall affinity of Ubiquitin over that of the binding to either motif
separately. During endocytosis, the bound Ubiquitin may come
from the free cellular pool or from monoubiquitinated substrates.
The latter form of the ligand may serve to ‘‘cross link’’ the higher
order species formed, and may bind with a different affinity from
free ubiquitin.
The study of biochemistry inside living cells entails utilizing
complementary methods to resolve processes on different scales
from micrometers to Angstroms. Light and fluorescence micros-
copy were successfully applied to study the localization and
compartmentalization of macromolecules in vivo on the microme-
ter scale. Fo ¨rster resonance energy transfer (FRET) extended our
ability to identify protein-protein and protein-nucleic acid
interactions on a scale of tens of nanometers and facilitated
estimates of binding affinities and stoichiometries [24]. The advent
of in-cell biochemistry using STINT-NMR, which allows us to
modify and examine protein-protein interaction surfaces at the
level of single amino acid residues, has pushed the limits of
resolution to the subnanometer scale. Though in its infancy, this
technique has the potential to open a window for investigating life
processes inside a living cell at a level of detail never seen before.
Materials and Methods
Sequential over-expression and labeling
E.coli strain BL21(DE3) codon+[Novagen] was co-transformed
with pASK-Ubq and: pCDF-ST2 (Ubq-STAM2 interaction); or
pRSF-Hrs (Ubq-Hrs interaction); or pCDFDuet-Hrs-ST2 (Ubq-
STAM2-Hrs interaction); or pCDF-ST2 and pDB1-Fyn (Ubq-
phosphorylated STAM2 interaction); or pCDFDuet-Hrs and
pDB1-Fyn (Ubq-phosphorylated Hrs interaction); or pCDFDuet-
Hrs-ST2 and pDB1-Fyn (Ubq-phosphorylated STAM2-Hrs
interaction). (For details of plasmid constructions see Methods S1).
Cells were grown overnight at 37uCt oa nO D 600 of $1.6 in
Luria-Bertani medium (LB) supplemented with 150 mg/L of
carbenicillin for cultures containing pASK-Ubq, 35 mg/L of
kanamycin for cultures containing pRSF-Hrs or pDB1-Fyn, and
50 mg/L of streptomycin for cultures containing pCDF-ST2 or
pCDFDuet-Hrs or pCDFDuet-Hrs-ST2. Cultures containing
pDB1-Fyn were supplemented with 0.2% glucose to suppress fyn
transcription from the PBAD promoter.
Two protocols were employed: In the first, the Ubiquitin target
was overexpressed and labeled followed by overexpression of the
interactor(s) and Fyn kinase; in the second, the interactor(s) and
Fyn kinase were overexpressed followed by overexpression and
labeling of the Ubiquitin target. The first protocol yielded a high
concentration ratio of labeled target to interactor, while the second
yielded a low ratio of target to interactor. Both protocols were
required to assess the endpoint of the structural transition.
Protocol 1: Expression of [U-
15N]-Ubiquitin
Cells from the overnight culture were washed once with minimal
medium (M9) salts and re-suspended to an OD600 of ,0.5 in M9
medium containing the appropriate antibiotics, [U-
15N] ammoni-
um chloride (0.7 g/L) as the sole nitrogen source and either 0.2%
glucose (for cultures containing pDB1-Fyn) or 0.4% glycerol as the
sole carbon source. N.b. For all induced cultures we substituted
ampicillin (100 mg/L) for carbenicillin. The cells were incubated at
37uC for 10–15 minutes and Ubiquitin overexpression was induced
by adding 2 mg/mL anhydrotetracycline in dimethylformamide to
a final concentration of 0.2 mg/mL. Ubiquitin overexpression was
allowed to proceed for up to 4 hours.
Following the first induction, a 100 mL sample of culture was
collected, the cells were centrifuged, washed twice with 50 mL of
10 mM potassium phosphate buffer [pH 7], resuspended with
1 mL 10 mM potassium phosphate buffer [pH 7.0] containing
10% glycerol and stored at 280uC for subsequent NMR analysis.
This control sample was used to assess the extent of overexpression
and quality of labeling for a given experiment.
Expression of STAM2, Hrs and Fyn kinase domain
Following Ubiquitin overexpression and labeling, the culture
was centrifuged and washed once with M9 salts before
resuspending a sufficient number of cells to yield an OD600 of
,0.5 in LB medium supplemented with the appropriate
antibiotics. The culture was incubated at 37uC for 10–15 minutes
and 0.5 M IPTG was added to a final concentration of 0.5 mM to
induce individual over-expression of STAM2 or Hrs, or 2 mM to
induce simultaneous overexpression of STAM2 and Hrs; induc-
tion was allowed to proceed for 3 or 4 hours. In phosphorylation
experiments, following 1 or 2 hours of IPTG induction, 20% L-
arabinose was added to a final concentration of 0.2%, and
overexpression of the Fyn kinase was allowed to proceed for
2 hours. 100 mL samples were taken, centrifuged, washed twice
with 10 mM potassium phosphate buffer [pH 7], resuspended
with 1 mL 10 mM potassium phosphate buffer [pH 7.0] contain-
ing 10% glycerol and stored at 280uC for subsequent NMR
analysis. The use of a cryoprotectant is critical to eliminate cell
lysis or breakage due to repeated freeze-thawing.
Protocol 2: Expression of STAM2, Hrs and Fyn kinase
domain
Cells from the overnight culture were washed once with minimal
medium (M9) salts and re-suspended to an OD600 of ,0.5 in LB
medium supplemented with the appropriate antibiotics. The culture
was incubated at 37uC for 10–15 minutes and 0.5 M IPTG was
added to a final concentration of 0.5 mM to induce individual over-
expression of STAM2 or Hrs, or 2 mM to induce simultaneous
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proceed for 3 or 4 hours. In phosphorylation experiments, following
1 or 2 hours of IPTG induction, 20% L-arabinose was added to a
final concentration of 0.2%, and overexpression of the Fyn kinase
was allowed to proceed for 2 hours.
Separately, a sufficient volume of overnight culture was
centrifuged, washed once with minimal medium (M9) salts and
re-suspended to an OD600 of ,0.5 in M9 medium containing the
appropriate antibiotics, [U-
15N] ammonium chloride (0.7 g/L) as
the sole nitrogen source and either 0.2% glucose (for cultures
containing pDB1-Fyn) or 0.4% glycerol or as the sole carbon
source. The cells were incubated at 37uC for 10–15 minutes and
Ubiquitin over-expression was induced by adding 2 mg/mL
anhydrotetracycline in dimethylformamide to a final concentra-
tion of 0.2 mg/mL. After 4 hours of induction, a 100 mL sample
of culture was collected, centrifuged, washed twice with 50 mL of
10 mM potassium phosphate buffer [pH 7], resuspended with
1 mL 10 mM potassium phosphate buffer [pH 7.0] containing
10% glycerol and stored at 280uC for subsequent NMR analysis.
This control sample was used to assess the extent of overexpression
and quality of labeling for a given experiment.
Expression of [U-
15N]-Ubiquitin
Following overexpression of the interactor (with or without post-
translational modification), the culture was centrifuged and washed
oncewithM9saltsbeforeresuspendingasufficientnumberofcellsto
yield an OD600 of ,0.5 in M9 medium containing the appropriate
antibiotics, [U-
15N] ammonium chloride (0.7 g/L) as the sole
nitrogen source and either 0.2% glucose (for cultures containing
pDB1-Fyn.) or 0.4% glycerol as the sole carbon source. The cells
were incubated at 37uC for 10–15 minutes and Ubiquitin over-
expression was induced by adding 2 mg/mL anhydrotetracycline in
dimethylformamide to a final concentration of 0.2 mg/mL.
Ubiquitin over-expression was allowed to proceed for 2, 3 or
4 hours. 100 mL samples were taken, centrifuged, washed twice
with 10 mM potassium phosphate buffer [pH 7], resuspended with
1 mL 10 mM potassium phosphate buffer [pH 7.0] containing 10%
glycerol and stored at 280uC forsubsequent NMR analysis.The use
of a cryoprotectant is critical to eliminate celllysis or breakage due to
repeated freeze-thawing.
Quantitation of intracellular STAM2 and Hrs
To estimate the concentration of overexpressed STAM2 and
Hrs present in cells, 10% SDS-PAGE was performed. Each gel
contained a concentration range of purified STAM2 to generate a
standard curve and samples from induced cells for each of the
overexpression time points used in the STINT-NMR titration
experiments. Gels were stained with SYPRO Ruby Gel Stain (Bio-
Rad), which provides a linear fluorescent response over a wide
range of protein concentration, and scanned using a Typhoon
Trio Variable Mode Imager (Amersham). The scanned gels were
analyzed using ImageQuant5.2 software (Molecular Dynamics).
Blocked bands were corrected for background and the unknown
samples were also corrected by subtracting the fluorescent optical
density of a sample that was not induced for protein overexpres-
sion. We assumed 4.4610
8 cells per mL per optical density unit at
600 nm and a cell volume of 4.2610
215 L, modeled as a sphere of
2 mm in diameter. The experiments were performed in duplicate.
NMR spectroscopy
[U-
15N]labeledcells werere-suspended in0.5 mLof NMR buffer
(10 mM potassium phosphate, pH 7.0, 90%/10% H2O/D2O) and
transferred to an NMR tube. To rule out the possibility that the
visible NMR spectrum was due to extracellular proteins due to
leakage from the cells, we sedimented the cells from the NMR
sample and acquired the
1H{
15N}-HSQC spectrum of the resultant
supernatant (Figure S1). No protein NMR signal was visible above
the noise level. All NMR experiments were performed using a
Bruker Avance 700 MHz NMR spectrometer equipped with a
cryoprobe. The cryoprobe affords a four-fold increase in sensitivity
allowing data collection within ,1 hr for an individual experiment;
this is critical to minimize cell leakage [17]. We used a watergate
version of the
1H{
15N}-HSQC spectrum.
1H{
15N}-edited HSQC
data were recorded with 32 transients as 512{64} complex points,
apodized with a squared cosine-bell window function and zero-filled
to 1k{128} points prior to Fourier transformation. The correspond-
ing sweep widths were 12 and 35 ppm in the
1Ha n d
15N
dimensions, respectively. Chemical shifts of [U-,
15N]-Ubiquitin
inside the cell are slightly different from purified Ubiquitin. We
reassigned the backbone chemical shifts of Ubiquitin using the
clarified lysate of [U-,
13C,
15N]-Ubiquitin and a standard suite of
triple resonance experiments [25]. During in-cell titration experi-
ments, we measured the change in the chemical shifts of amide
nitrogens and covalently attached amide protons according to the
equation: DV~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
d
2
Hz 0:251dN ðÞ
2
q
,w h e r edH(N) represents a
change in hydrogen and nitrogen chemical shifts. Even without
quantifying protein concentrations present in the cell, in-cell NMR
spectroscopy allows us to make a crude estimate of the protein
binding affinities. Depending on the magnitude of the chemical shift
change DVand therate constant, koff, between bound and free states,
chemical exchange can result in gradual changes of chemical shifts
when DV,,koff (fast exchange), line broadening when DV#koff
(intermediate exchange) or the appearance of new peaks when
DV..koff (slow exchange). Assuming that the binding reaction is
diffusion limited and the average change of the chemical shift is
,0.01 ppm, the fast exchange regime will occur when the
dissociation constant, Kd,i sl a r g e rt h a n1 0 0mM and intermediate
or slow exchange will occur when the dissociation constant is less
than or equal to 10 mM.
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